Danaher Corporation

NYSE:DHR

Market Cap

USD 143.85 B

Share Price

USD 201.00

Avg Daily Volume

4,113,593

Change (1 day)

1.79%

Change (1 year)

-20.91%

Change (YTD)

-12.44%

Danaher Corporation Shareholders' Equity for the year ending December 31, 2024: USD 49.54 B

Danaher Corporation Shareholders' Equity is USD 49.54 B for the year ending December 31, 2024, a -7.37% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Danaher Corporation Shareholders' Equity for the year ending December 31, 2023 was USD 53.49 B, a 6.80% change year over year.
  • Danaher Corporation Shareholders' Equity for the year ending December 31, 2022 was USD 50.08 B, a 10.88% change year over year.
  • Danaher Corporation Shareholders' Equity for the year ending December 31, 2021 was USD 45.17 B, a 13.58% change year over year.
  • Danaher Corporation Shareholders' Equity for the year ending December 31, 2020 was USD 39.77 B, a 31.37% change year over year.
Key data
Date Shareholders' Equity Cash and Short-Term Investments Receivables Inventory
Market news
Loading...
NYSE: DHR

Danaher Corporation

CEO Mr. Rainer M. Blair
IPO Date Dec. 29, 1978
Location United States
Headquarters 2200 Pennsylvania Avenue, NW
Employees 61,000
Sector 🏥 Health Care
Industries
Description

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Similar companies

A

Agilent Technologies, Inc.

USD 118.62

0.83%

600010.SS

Inner Mongolia Baotou Steel Union Co., Ltd.

USD 0.25

0.22%

QGEN

Qiagen N.V.

USD 47.45

0.47%

TECH

Bio-Techne Corporation

USD 51.89

3.78%

BRKR

Bruker Corporation

USD 40.93

3.20%

TECN.SW

Tecan Group AG

USD 199.32

-0.65%

688068.SS

Beijing Hotgen Biotech Co., Ltd.

USD 18.64

-2.50%

EUZ.DE

Eckert & Ziegler Strahlen- und Medizintechnik AG

USD 78.00

1.57%

688289.SS

Sansure Biotech Inc.

USD 2.86

-0.42%

RO.SW

Roche Holding AG

USD 341.12

-1.04%

ABT

Abbott Laboratories

USD 137.40

-0.49%

BSX

Boston Scientific Corporation

USD 104.29

0.16%

TMO

Thermo Fisher Scientific Inc.

USD 410.65

1.55%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 52.21

0.11%

SHL.DE

Siemens Healthineers AG

USD 54.76

0.58%

MRK.DE

MERCK Kommanditgesellschaft auf Aktien

USD 128.65

-0.79%

BDX

Becton, Dickinson and Company

USD 170.90

-0.39%

GEHC

GE HealthCare Technologies Inc.

USD 72.75

1.07%

4543.T

Terumo Corporation

USD 18.48

0.13%

4901.T

FUJIFILM Holdings Corporation

USD 21.65

0.88%

NTRA

Natera, Inc.

USD 164.16

-4.49%

DIM.PA

Sartorius Stedim Biotech S.A.

USD 231.65

0.12%

LH

Laboratory Corporation of America Holdings

USD 258.70

-1.46%

WAT

Waters Corporation

USD 350.01

0.93%

BIM.PA

bioMérieux S.A.

USD 139.32

-0.41%

HLMA.L

Halma plc

USD 43.74

1.62%

WST

West Pharmaceutical Services, Inc.

USD 221.02

-0.74%

BAX

Baxter International Inc.

USD 30.61

0.07%

IEX

IDEX Corporation

USD 174.50

-0.22%

SN.L

Smith & Nephew plc

USD 14.98

0.72%

RVTY

Revvity, Inc.

USD 97.70

1.36%

603392.SS

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.57

-0.69%

6869.T

Sysmex Corporation

USD 17.09

0.34%

EXAS

Exact Sciences Corporation

USD 51.92

1.47%

AVTR

Avantor, Inc.

USD 13.58

0.89%

CTEC.L

ConvaTec Group Plc

USD 3.96

0.77%

GMED

Globus Medical, Inc.

USD 58.19

-0.80%

AUROPHARMA.NS

Aurobindo Pharma Limited

USD 13.10

0.64%

4188.T

Mitsubishi Chemical Group Corporation

USD 5.14

0.99%

7701.T

Shimadzu Corporation

USD 24.12

1.02%

RGEN

Repligen Corporation

USD 124.02

0.54%

BIO

Bio-Rad Laboratories, Inc.

USD 240.98

1.29%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 8.00

0.06%

DIA.MI

DiaSorin S.p.A.

USD 109.19

-0.66%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.54

-5.44%

000100.KS

Yuhan Corporation

USD 74.84

0.37%

LNTH

Lantheus Holdings, Inc.

USD 80.55

-0.49%

688617.SS

APT Medical Inc.

USD 41.26

1.54%

BANB.SW

Bachem Holding AG

USD 72.14

-0.89%

3759.HK

Pharmaron Beijing Co., Ltd.

USD 2.00

-2.35%

StockViz Staff

June 27, 2025

Any question? Send us an email